[1]
“Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion”, Nep J Oph, vol. 12, no. 2, pp. 281–289, Oct. 2020, doi: 10.3126/nepjoph.v12i2.28761.